These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 5765721)
1. The concept of drug expiration dating. Wollish EG Bull Parenter Drug Assoc; 1969; 23(1):48-52. PubMed ID: 5765721 [No Abstract] [Full Text] [Related]
2. Drug safety: the viewpoint of the pharmaceutical manufacturing industry. Wigle WW Can Med Assoc J; 1968 Feb; 98(6):314-7. PubMed ID: 5636099 [No Abstract] [Full Text] [Related]
3. Stability analysis for drugs with multiple active ingredients. Chow SC; Shao J Stat Med; 2007 Mar; 26(7):1512-7. PubMed ID: 16955533 [TBL] [Abstract][Full Text] [Related]
4. Improving drug quality through certification experience. Weiss PJ Am J Pharm Sci Support Public Health; 1974; 146(3):86-90. PubMed ID: 4852375 [No Abstract] [Full Text] [Related]
5. Drug product expiration dates: practice implications. MacDonnell CP; Campbell NA Med Health R I; 2002 Apr; 85(4):136-7. PubMed ID: 11989404 [No Abstract] [Full Text] [Related]
6. Expiration dating needed to ensure medications' potency, safety, suitability for use. Bowles GC Mod Hosp; 1972 Nov; 119(5):130. PubMed ID: 5080106 [No Abstract] [Full Text] [Related]
7. Expiration dating of drugs under way. Cohn JP Am Pharm; 1980 Mar; NS20(3):10. PubMed ID: 7369125 [No Abstract] [Full Text] [Related]
9. New classification of drugs. J Fla Med Assoc; 1972 Jan; 59(1):37. PubMed ID: 5058956 [No Abstract] [Full Text] [Related]
10. How do expiration and beyond-use dates compare? Ohler J; Miller C; Sheridan D Nursing; 2019 Mar; 49(3):17. PubMed ID: 30801402 [No Abstract] [Full Text] [Related]
11. Influence of compounding on sterility and stability of drugs. Hardee GE J Am Vet Med Assoc; 1994 Jul; 205(2):224-5. PubMed ID: 7928582 [No Abstract] [Full Text] [Related]
12. F.D.A. to assess O.T.C. drugs for safety, efficacy, labeling. Bowles GC Mod Hosp; 1972 Mar; 118(3):126. PubMed ID: 5058060 [No Abstract] [Full Text] [Related]
13. Drug rackets. Mani MK Natl Med J India; 2010; 23(4):242-3. PubMed ID: 21192523 [No Abstract] [Full Text] [Related]
14. Therapeutic orphans: who speaks for children? Shirkey HC South Med J; 1970 Nov; 63(11):1361-3. PubMed ID: 5475304 [No Abstract] [Full Text] [Related]
15. Getting the upper hand on expired drugs. Wick JY Consult Pharm; 2010 Feb; 25(2):122-4. PubMed ID: 20211825 [No Abstract] [Full Text] [Related]
16. Evaluating the performance of the ICH guidelines for shelf life estimation. Quinlan M; Stroup W; Schwenke J; Christopher D J Biopharm Stat; 2013; 23(4):881-96. PubMed ID: 23786363 [TBL] [Abstract][Full Text] [Related]
17. Expiration and beyond-use dates. Okeke CC; Srinivasan VS Am J Health Syst Pharm; 1998 Mar; 55(5):433-4. PubMed ID: 9522923 [No Abstract] [Full Text] [Related]
18. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products. Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700 [No Abstract] [Full Text] [Related]
19. Drug therapy today: DESI ratings, a revolution in the making. DiPalma JR RN; 1973 Jun; 36(6):51-63. PubMed ID: 4488242 [No Abstract] [Full Text] [Related]
20. Institute of Medicine's new drug safety report: implications for Canada. Cassels A CMAJ; 2006 Dec; 175(12):1515-6. PubMed ID: 17146086 [No Abstract] [Full Text] [Related] [Next] [New Search]